Stefanie Rechtsteiner

Boehringer Ingelheim

Stefanie has worked for more than 15 years in various fields within the pharmaceutical industry. After several years in biotech and in sales she moved to pharmacovigilance where she specialised in safety writing from 2011 onwards. She has extensive hands-on experience on DSUR, RMP and PBRER writing and currently works as a senior pharmacovigilance writer at Boehringer Ingelheim. Stefanie joined EMWA in 2011 and is a member of the EMWA Finance Committee.